NurExone Biologic Inc.
NRXBF
$0.40
$0.000.40%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.51M | 2.14M | 983.00K | 1.23M | 588.00K |
| Total Receivables | 153.00K | 89.00K | 122.00K | 84.00K | 135.00K |
| Inventory | -- | -- | -- | 600.00K | 600.00K |
| Prepaid Expenses | -- | 95.00K | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 44.00K | 279.00K | 41.00K | 41.00K | 41.00K |
| Total Current Assets | 1.71M | 2.60M | 1.15M | 1.95M | 1.36M |
|
|
|||||
| Total Current Assets | 1.71M | 2.60M | 1.15M | 1.95M | 1.36M |
| Net Property, Plant & Equipment | 822.00K | 864.00K | 882.00K | 911.00K | 776.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 618.00K | 618.00K | 618.00K | -- | -- |
| Total Assets | 3.15M | 4.08M | 2.65M | 2.86M | 2.14M |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 454.00K | 690.00K | 366.00K | 329.00K | 187.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 38.00K | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 310.00K | 261.00K | 496.00K | 678.00K | 366.00K |
| Total Other Current Liabilities | 310.00K | 261.00K | 496.00K | 678.00K | 366.00K |
| Total Current Liabilities | 764.00K | 989.00K | 862.00K | 1.01M | 553.00K |
|
|
|||||
| Total Current Liabilities | 764.00K | 989.00K | 862.00K | 1.01M | 553.00K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 68.00K | 70.00K | 79.00K | 91.00K | 31.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 313.00K | 266.00K | 248.00K | 234.00K | 240.00K |
| Total Liabilities | 1.15M | 1.33M | 1.19M | 1.33M | 824.00K |
|
|
|||||
| Common Stock & APIC | 26.78M | 26.09M | 23.82M | 22.75M | 20.41M |
| Retained Earnings | -27.25M | -25.48M | -24.09M | -22.62M | -20.78M |
| Treasury Stock & Other | 2.47M | 2.15M | 1.72M | 1.40M | 1.68M |
| Total Common Equity | 2.00M | 2.76M | 1.46M | 1.53M | 1.32M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.00M | 2.76M | 1.46M | 1.53M | 1.32M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.00M | 2.76M | 1.46M | 1.53M | 1.32M |
|
|
|||||